Ningxia Zhongke Biotechnology Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Rui Chen
Chief executive officer
CN¥264.5k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 2.5yrs |
Recent management updates
Recent updates
Revenues Not Telling The Story For Ningxia Zhongke Biotechnology Co., Ltd (SHSE:600165) After Shares Rise 25%
Nov 13
What Ningxia Zhongke Biotechnology Co., Ltd's (SHSE:600165) 34% Share Price Gain Is Not Telling You
Aug 30Ningxia Zhongke Biotechnology Co., Ltd (SHSE:600165) Looks Just Right With A 50% Price Jump
Jul 12Calculating The Intrinsic Value Of Ningxia Zhongke Biotechnology Co., Ltd (SHSE:600165)
Jun 03Ningxia Zhongke Biotechnology Co., Ltd (SHSE:600165) Shares Slammed 30% But Getting In Cheap Might Be Difficult Regardless
Apr 21Ningxia Zhongke Biotechnology Co., Ltd's (SHSE:600165) 29% Cheaper Price Remains In Tune With Revenues
Feb 27CEO
Rui Chen (50 yo)
no data
Tenure
CN¥264,500
Compensation
Mr. Rui Chen serves as General Manager of Ningxia Zhongke Biotechnology Co., Ltd. and served as its Director until July 01, 2022. Mr. Chen served as Chief Financial Officer of Ningxia Zhongke Biotechnology...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Director | 2.5yrs | CN¥33.30k | no data | |
| Independent Director | 2.5yrs | CN¥80.00k | no data | |
| Director | 2.5yrs | no data | no data | |
| Chairman of the Supervisory Board | no data | no data | no data | |
| Supervisor | no data | no data | no data | |
| Director | 2.5yrs | no data | no data | |
| Independent Director | 2.5yrs | CN¥33.30k | no data | |
| Director | 3.1yrs | no data | no data | |
| Supervisor | 2.8yrs | no data | no data | |
| Chairman | 2.5yrs | no data | no data | |
| Independent Director | 2.5yrs | CN¥80.00k | no data |
2.5yrs
Average Tenure
54yo
Average Age
Experienced Board: 600165's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/08 20:41 |
| End of Day Share Price | 2025/01/08 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Ningxia Zhongke Biotechnology Co., Ltd is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Wei Liu | Haitong International Research Limited |